Steven Kregel

8PUBLICATIONS
81CO-AUTHORS
Radiation therapyMolecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 14, 2026
Dose-Escalated Focal Salvage High-Dose-Rate Brachytherapy and Genomic Classifier Risk Stratification in Radiorecurrent Prostate Cancer: The F-SHARP Phase I/II Clinical Trial.

|Jul 17, 2026
A non-enzymatic role for METTL3 as an Androgen Receptor co-regulator that promotes prostate cancer proliferation.

|Aug 12, 2025
SOX2 utilizes FOXA1 as a heteromeric transcriptional partner to drive proliferation in therapy-resistant prostate cancer.

John T Phoenix, Audris Budreika, Devin A Schmeck

|Jan 25, 2025
The Homeobox Transcription Factor NKX3.1 Displays an Oncogenic Role in Castration-Resistant Prostate Cancer Cells.

Audris Budreika, John T Phoenix, Raymond J Kostlan

|Nov 12, 2024
An Autophagy-Targeting Chimera Induces Degradation of Androgen Receptor Mutants and AR-v7 in Castration-Resistant Prostate Cancer.

Tae Hyun Bae, Ki Woon Sung, Tri M Pham

|May 31, 2024
Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation.

Raymond J Kostlan, John T Phoenix, Audris Budreika

Pageof 2

Frequent Collaborators

4 joint publications

John T Phoenix

4 joint publications

Donald Vander Griend

3 joint publications

Audris Budreika

3 joint publications

Raymond J Kostlan